Maryland Industrial Partnerships accelerates technology commercialization by providing funding for collaborative research projects between companies and faculty in the University of Maryland system and other Maryland Universities.
Shira Kramer has been president of Sterilex Corporation since its inception in 1995 and has been instrumental in its growth during the past 17 years.
When asked about the award, Dr Kramer commented, “Sterilex is honored to receive this award from MIPS, which has supported the vital role of life science innovation in the economy of the state of Maryland. I would like to acknowledge the significant contribution of the employees of Sterilex in the continuing growth of our company.”
Sterilex Corporation is a leader in developing patented antimicrobial, anti-biofilm, and specialty cleaning products to address the decontamination of pathogens, spoilage organisms, resistant biofilms, pesticides/chemicals, and organic residues in diverse industries. The Sterilex product line includes EPA-registered antimicrobial products for biofilm removal and pathogen control, as well as specialty cleaning and decontaminating agents. Sterilex sells disinfectants, anti-biofilm biocides, cleaning, and decontaminating products to the health care, dental care, water care, industrial, food processing, and environmental remediation industries.